tacrine has been researched along with berlition in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Bartolini, M; Bolognesi, ML; Hrelia, P; Melchiorre, C; Minarini, A; Rosini, M; Tarozzi, A | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bautista-Aguilera, OM; Benchekroun, M; Buendía, I; Egea, J; Ismaili, L; Janockova, J; Jimeno, ML; Jun, D; León, R; Marco-Contelles, J; Michalska, P; Ouari, O; Refouvelet, B; Romero, A; Sepsova, V; Soukup, O | 1 |
1 review(s) available for tacrine and berlition
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
3 other study(ies) available for tacrine and berlition
| Article | Year |
|---|---|
Rational approach to discover multipotent anti-Alzheimer drugs.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Humans; Neurons; Nootropic Agents; Reactive Oxygen Species; Structure-Activity Relationship; Tacrine; Thioctic Acid | 2005 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
Topics: Alzheimer Disease; Antioxidants; Cell Death; Cell Survival; Cholinesterase Inhibitors; Cholinesterases; Coumaric Acids; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Melatonin; Molecular Structure; NF-E2-Related Factor 2; Structure-Activity Relationship | 2016 |